Assessment of the Prevalence of Anxiety and Depressive Symptoms, Life Satisfaction and Quality of Life Among Women in the Maternity Ward with the Impact of the COVID-19 Pandemic.

Assessment of the Prevalence of Anxiety and Depressive Symptoms, Life Satisfaction and Quality of Life Among Women in the Maternity Ward with the Impact of the COVID-19 Pandemic.

Publication date: Sep 05, 2025

Background: The postpartum period may predispose to a higher prevalence of mental health disorders. The aim of the study was to assess the prevalence of anxiety and depressive symptoms, life satisfaction, and quality of life in breastfeeding women in the maternity ward in relation to specific medical and social factors. Methods: The study group consisted of 304 female patients from the maternity ward of the Multispecialist District Hospital in Tarnowskie GcF3ry, Poland. The research tool included four questionnaires: Hospital Anxiety Depression Scale, Edinburgh Postnatal Depression Scale, Satisfaction with Life Scale, and Euro-Quality of Life Questionnaire. Results: The majority of women in the maternity ward reported good psychological well-being. Anxiety symptoms affected 11. 9% of postpartum women, depressive symptoms-7. 3%, and symptoms of postpartum depression-5. 9%. The COVID-19 pandemic caused an increase in anxiety and depressive disorders (relative differences-expressed as a percentage). Women who gave birth by cesarean section were more likely to declare problems that negatively impacted their quality of life and health than those who gave birth naturally (OR = 1. 28, 95% CI: 0. 77-2. 11). The risk of experiencing anxiety and depressive symptoms, as well as postpartum depression symptoms decreased as self-rated health increased (OR = 0. 96, 95% CI: 0. 94-0. 99; OR = 0. 96, 95% CI: 0. 94-0. 99; OR = 0. 96, 95% CI: 0. 93-0. 98, respectively). Higher level of life satisfaction was associated with higher levels of education and economic status, attendance at childbirth classes, and a higher self-assessment of health (OR = 4. 1, 95% CI: 1. 6-10. 51; OR = 2. 96, 95% CI: 1. 41-6. 24; OR = 1. 99, 95% CI: 1. 13-3. 49; OR = 1. 01, 95% CI: 1. 01-1. 04, respectively). Conclusions: Screening for mental disorders during the postpartum period enables the early identification of symptoms and the implementation of appropriate treatment. Women who give birth by cesarean section and have medical complaints should be given special follow-up care. Health policy should ensure wider access to psychological and psychiatric care during the postpartum period.

Open Access PDF

Concepts Keywords
Childbirth anxiety
Depressive COVID-19 pandemic
Education depression
Euro life satisfaction
Postnatal postpartum depression
quality of life

Semantics

Type Source Name
disease MESH Anxiety
disease MESH Depressive Symptoms
disease IDO quality
disease MESH COVID-19 Pandemic
disease MESH Postnatal Depression
disease MESH psychological well-being
disease MESH depressive disorders
disease MESH mental disorders
disease IDO role
disease MESH psychosis
disease MESH post traumatic stress disorder
disease MESH anxiety disorders
drug DRUGBANK Coenzyme M
disease MESH physiological stress
drug DRUGBANK Hydrocortisone
drug DRUGBANK p-Phenylenediamine
disease IDO history
disease MESH mood disorders
disease MESH unplanned pregnancy
disease MESH miscarriages
disease MESH stillbirths
disease MESH high risk pregnancy
pathway KEGG Circadian rhythm
disease MESH insomnia
disease MESH disorientation
disease MESH delusions
disease MESH hallucinations
disease MESH suicide
disease MESH bipolar disorder
disease MESH schizophrenia
disease MESH complications
disease MESH emergency
disease MESH preterm labor
drug DRUGBANK Pentaerythritol tetranitrate
drug DRUGBANK Aspartame
disease MESH marital status
drug DRUGBANK Esomeprazole

Original Article

(Visited 5 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *